Matthew Urbik

Matthew Urbik is a corporate development professional at Caris Life Sciences since July 2023, with a robust background in investment banking and equity research. Prior experience includes roles as an Investment Banking Associate and Analyst at Credit Suisse focusing on healthcare coverage, as well as an Equity Research Associate specializing in life science tools and diagnostics. Matthew also held positions at the University of Dayton's Davis Center for Portfolio Management, progressing from Analyst to Senior Manager, and served as a Sector Leader at Global Platinum Securities. Additional experiences include summer analyst roles at J.P. Morgan and Dresner Partners. Matthew Urbik earned a Bachelor's Degree in Accounting and Finance from the University of Dayton in 2019.